China has just approved its first brain implant for commercial use, a world first

China has just approved its first brain implant for commercial use, a world first

March 13, 2026

2 minutes of reading

Add us on GoogleAdd science

Neuracle Medical Technology’s invasive brain-computer interface given the green light in China for people with partial spinal cord injuries

By Lewis asked. edited by Claire Cameron

Illustration of the human brain, lit from the inside

Juan Gaertner/Scientific Photo Library/Getty Images

Join our community of science lovers!

In a world first, China has approved a brain implant intended for commercial use in people with spinal cord injuries.

The device is a type of brain-computer interface (BCI) and is made by Shanghai-based Neuracle Medical Technology, a potential rival to Elon Musk’s BCI startup. Neural link. Brain implants have been used in clinical trials for decades, but this is the first time such a device has been approved for widespread use in patients.

BCIs, sometimes called brain-machine interfaces, are devices that record brain activity. Invasive BCIs like Neuracle’s are surgically implanted in or on the brain. There, they record the electrical signals from the neurons. Software then “decodes” these signals, which can then be used to control a computer cursor or prosthesis, for example.


On supporting science journalism

If you enjoy this article, please consider supporting our award-winning journalism by subscribe. By purchasing a subscription, you are helping to ensure the future of impactful stories about the discoveries and ideas shaping our world today.


The Neuracle BCI consists of a wireless implant the size of a coin which sits on the surface of the brain’s outer membrane and controls a robotic glove. It is designed specifically for people with spinal cord injuries, but is only approved for people who still have some function in their upper arm. BCIs in general are typically developed for use by people with paralysis or other disabilities. Neuralink’s Musk has talked about one day making them accessible to people without health problems, but that app is further away.

One of the first (and still one of the main) BCIs was created in the early 2000s by a research consortium called Brain holder. The device allows study participants with locked-in syndrome, which involves total paralysis caused by stroke or injury, to control a computer mouse and type on a virtual keyboard. Since then, other research groups have developed devices capable of achieving similar feats.

In the United States, Musk’s Neuralink has come closest to commercializing the technology, but questions remain about the device’s security. In 2022, the The Food and Drug Administration initially rejected an offer for Neuralink to test its technology in a clinical trial. A trial was finally approved the following year, and then Noland Arbaugh, 30, paralyzed below the neck, became the first user to have a Neuralink implant. In January 2026, the company said it had 21 participants registered for his test.

Other US start-ups, such as Synchron and Paradromics, are developing their own BCIs and also have ongoing trials.

But even though there is compelling evidence from these clinical tests, the devices are still considered experimental. After all, installing brain implants requires brain surgery, which is highly invasive and carries a risk of infection and complications. And implants can sometimes move or cause scar tissue to build up over time, which degrades their signals. No BCI devices have been approved for commercial use in the United States

It’s time to defend science

If you enjoyed this article, I would like to ask for your support. Scientific American has been defending science and industry for 180 years, and we are currently experiencing perhaps the most critical moment in these two centuries of history.

I was a Scientific American subscriber since the age of 12, and it helped shape the way I see the world. SciAm always educates and delights me, and inspires a sense of respect for our vast and beautiful universe. I hope this is the case for you too.

If you subscribe to Scientific Americanyou help ensure our coverage centers on meaningful research and discoveries; that we have the resources to account for decisions that threaten laboratories across the United States; and that we support budding and working scientists at a time when the value of science itself too often goes unrecognized.

In exchange, you receive essential information, captivating podcastsbrilliant infographics, newsletters not to be missedunmissable videos, stimulating gamesand the best writings and reports from the scientific world. You can even give someone a subscription.

There has never been a more important time for us to stand up and show why science matters. I hope you will support us in this mission.

Exit mobile version